Our resilient flooring products utilize vulcanized composition rubber to:
- Reduce the risk of injury from a fall
- Quiet the environment for healing and focus
- Enhance staff well-being
Get ready to reopen and stay open with our free resources, including floor cleaning videos. Learn More
Safety
Our products are unique because they provide more.
Ecore provides a variety of premium flooring products developed and manufactured to meet the extreme challenges experienced in commercial environments, including healthcare, senior living, hospitality, public spaces, multifamily, retail, corporate and education facilities.
Our flooring is quieter, more ergonomic and safer.
Leveraging Ecore's patented itsTRU™ technology, our Rx products provide force reduction and energy restitution in every step.
How Ergonomic Is Your Surface?
1. Concrete, 2. Heterogeneous Sheet Vinyl 2mm, 3. Rubber Sheet 2mm, 4. Homogeneous Sheet Vinyl 2mm, 5. VCT, 6. Linoleum, 7. Forest Rx, 8. Aurora, 9. Strait Rx, 10. Carpet 34oz 1/10 ga loop
*Based on the Deltec Test
*Based on the Deltec Test
Falls and injuries from falls continue to persist throughout the commercial flooring environment, effecting overall quality of life
In all Commercial or public locations, slip reduction and injury mitigation lowers financial risk and liability.
1. Homogeneous Sheet Vinyl 2mm*, 2. Linoleum 2.5mm*, 3. LVT 2.5mm, 4. Heterogeneous Sheet Vinyl 2mm, 5. Rubber Sheet 2mm, 6. Aurora, 7. Forest/Strait Rx
*Exceeds test equipment limit of 1,000 G's.
*Exceeds test equipment limit of 1,000 G's.
Safety
How can a floor help prevent serious injuries when falls occur?
- Rx products have been tested for G-Max using the Clegg Machine protocol. A conventional mathematical formula is often used to convert Clegg test results to ASTM F355 result for comparison purposes.
- Using this protocol to compare traditional flooring products, the Ecore Rx surfacing technology demonstrates up to a 35.5% reduction in impact acceleration.
- At medical facilities, reducing injury from falls may reduce unbudgeted and nonreimbursable treatment charges.